Tilavonemab in early Alzheimer's disease: results from a phase 2, randomized, double-blind study. Florian H, Wang D, Arnold SE, Boada M, et al. Brain 2023 Feb 2:awad024. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Florian H, Wang D, Arnold SE, Boada M, et al. Tilavonemab in early Alzheimer's disease: results from a phase 2, randomized, double-blind study. Brain 2023 Feb 2:awad024. doi: 10.1093.
PMID: 36730056